Back to Search
ASHA POTTI, M.D
M.D
Internal Medicine Physician
NPI: 1801048293IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
MD037660(DC)D0070248(MD)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
OTHER
Class of 2000
Research & Publications (20)
Report on EU-USA workshop: how systems biology can advance cancer research (27 October 2008).
PMID 19383362·Mol Oncol·2009
8-other
Genomic and molecular profiling predicts response to temozolomide in melanoma.
PMID 19147755·Clin Cancer Res·2009
8-other
Characterizing the developmental pathways TTF-1, NKX2-8, and PAX9 in lung cancer.
PMID 19279207·Proc Natl Acad Sci U S A·2009
8-other
Gene expression profiles of tumor biology provide a novel approach to prognosis and may guide the selection of therapeutic targets in multiple myeloma.
PMID 19636021·J Clin Oncol·2009
8-other
An integration of complementary strategies for gene-expression analysis to reveal novel therapeutic opportunities for breast cancer.
PMID 19638211·Breast Cancer Res·2009
4-observational
A genomic strategy to elucidate modules of oncogenic pathway signaling networks.
PMID 19362539·Mol Cell·2009
4-observational
Translating genomics into clinical practice: applications in lung cancer.
PMID 19508830·Curr Oncol Rep·2009
6-review
Utilization of pathway signatures to reveal distinct types of B lymphoma in the Emicro-myc model and human diffuse large B-cell lymphoma.
PMID 18922927·Cancer Res·2008
7-preclinical
Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression.
PMID 18612148·J Clin Oncol·2008
4-observational
Utilization of genomic signatures to direct use of primary chemotherapy.
PMID 18339540·Curr Opin Genet Dev·2008
6-review
Age-specific differences in oncogenic pathway deregulation seen in human breast tumors.
PMID 18167534·PLoS One·2008
8-other
Genomic signatures individualize therapeutic decisions in non-small-cell lung cancer.
PMID 18020912·Expert Rev Mol Diagn·2007
6-review
Mining gene expression profiles: expression signatures as cancer phenotypes.
PMID 17607306·Nat Rev Genet·2007
6-review
Genomic signatures in non-small-cell lung cancer: targeting the targeted therapies.
PMID 17254524·Curr Oncol Rep·2006
6-review
Gene expression patterns that predict sensitivity to epidermal growth factor receptor tyrosine kinase inhibitors in lung cancer cell lines and human lung tumors.
PMID 17096850·BMC Genomics·2006
8-other
Adjuvant chemotherapy for early-stage non-small cell lung cancer: the past, the present and the future.
PMID 16805710·Expert Opin Biol Ther·2006
6-review
Defective myelin lipid synthesis as a pathogenic mechanism of Canavan disease.
PMID 16802710·Adv Exp Med Biol·2006
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1406 CRAIN HWY S, SUITE 108
GLEN BURNIE, MD 21061 - Phone
- (410) 760-0098
Quick Facts
- NPI
- 1801048293
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 26
- Publications
- 20
Are you this provider?
Claim Your Profile